PL431722A1 - Nowy szczep Lactobacillus fermentum PL9 i jego zastosowanie - Google Patents

Nowy szczep Lactobacillus fermentum PL9 i jego zastosowanie

Info

Publication number
PL431722A1
PL431722A1 PL431722A PL43172219A PL431722A1 PL 431722 A1 PL431722 A1 PL 431722A1 PL 431722 A PL431722 A PL 431722A PL 43172219 A PL43172219 A PL 43172219A PL 431722 A1 PL431722 A1 PL 431722A1
Authority
PL
Poland
Prior art keywords
strain
lactobacillus fermentum
application
new lactobacillus
new
Prior art date
Application number
PL431722A
Other languages
English (en)
Other versions
PL241599B1 (pl
Inventor
Piotr Heczko
Magdalena Strus
Original Assignee
Sanprobi Spółka Z Ograniczoną Odpowiedzialnością Spółka Komandytowa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanprobi Spółka Z Ograniczoną Odpowiedzialnością Spółka Komandytowa filed Critical Sanprobi Spółka Z Ograniczoną Odpowiedzialnością Spółka Komandytowa
Priority to PL431722A priority Critical patent/PL241599B1/pl
Priority to EP20460040.7A priority patent/EP3818985B1/en
Publication of PL431722A1 publication Critical patent/PL431722A1/pl
Publication of PL241599B1 publication Critical patent/PL241599B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Przedmiotem wynalazku jest nowy szczep Lactobacillus fermentum PL9 i jego zastosowanie do ochrony przed czynnikami patogennymi i wytwarzania środka poprawiającego funkcje bariery jelitowej i zapobiegania zakażeniom.
PL431722A 2019-11-06 2019-11-06 Szczep Lactobacillus fermentum PL9 i jego zastosowanie PL241599B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL431722A PL241599B1 (pl) 2019-11-06 2019-11-06 Szczep Lactobacillus fermentum PL9 i jego zastosowanie
EP20460040.7A EP3818985B1 (en) 2019-11-06 2020-10-21 Lactobacillus fermentum pl9 and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL431722A PL241599B1 (pl) 2019-11-06 2019-11-06 Szczep Lactobacillus fermentum PL9 i jego zastosowanie

Publications (2)

Publication Number Publication Date
PL431722A1 true PL431722A1 (pl) 2021-05-17
PL241599B1 PL241599B1 (pl) 2022-11-07

Family

ID=73449002

Family Applications (1)

Application Number Title Priority Date Filing Date
PL431722A PL241599B1 (pl) 2019-11-06 2019-11-06 Szczep Lactobacillus fermentum PL9 i jego zastosowanie

Country Status (2)

Country Link
EP (1) EP3818985B1 (pl)
PL (1) PL241599B1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116179444A (zh) * 2023-03-09 2023-05-30 卡士乳业(深圳)有限公司 一株发酵乳杆菌ckcc 1369菌株及其用途
CN116590373B (zh) * 2023-06-29 2023-11-17 广东海洋大学 一种发酵粘液乳杆菌胞外多糖、制备方法及应用
CN117143767B (zh) * 2023-08-23 2024-06-11 浙江民生健康科技有限公司 可调节肠道菌群的母乳源发酵粘液乳杆菌msjk0025及其应用
CN118557613B (zh) * 2024-08-01 2025-02-11 青岛元达生物科技有限公司 一种具有抑制细菌性腹泻致病菌的后生元的制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL106555B1 (pl) 1978-02-24 1979-12-31 Univ M Curie Sklodowskiej Elektroda impregnowana z grafitu spektralnie czystego i sposob otrzymywania elektrody impregnowanej z grafitu spektralnie czystego
PL112237B1 (en) 1978-10-21 1980-10-31 Zaklady Metali Lekkich Kety Multistage pneumatic control device for hydraulic distributors
KR101452234B1 (ko) * 2013-07-22 2014-10-22 (주) 피엘바이오 장수마을 성인으로부터 분리한 배변활동에 도움을 주는 신규한 유산균 락토바실러스 퍼멘텀
WO2017163216A1 (en) 2016-03-24 2017-09-28 Probiotical S.P.A. Lactic acid bacterial composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, of concurrent fungal infections
KR102024883B1 (ko) * 2017-11-24 2019-09-24 주식회사 고바이오랩 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도

Also Published As

Publication number Publication date
EP3818985B1 (en) 2022-01-05
EP3818985A1 (en) 2021-05-12
PL241599B1 (pl) 2022-11-07

Similar Documents

Publication Publication Date Title
PL431722A1 (pl) Nowy szczep Lactobacillus fermentum PL9 i jego zastosowanie
CY1121473T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1124013T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1125136T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
PE20181155A1 (es) Composiciones que comprenden cepas bacterianas
EP3737665A4 (en) PRODRUGS OF KETAMINE, COMPOSITIONS AND USES THEREOF
CL2018001368A1 (es) Composiciones que comprenden cepas bacterianas
CY1122148T1 (el) Συνθεσεις που περιεχουν βακτηριακα στελεχη
CL2018001358A1 (es) Composiciones que comprenden cepas bacterianas
CY1122867T1 (el) Συνθεσεις που περιλαμβανουν ενα βακτηριακο στελεχος του blautia hydrogenotrophica για χρηση στην θεραπεια ή προληψη διαρροιας ή δυσκοιλιοτητας
IL286079A (en) Imidazolonylquinoline compounds and therapeutic uses thereof
BR112015030389A2 (pt) uso de i) uma fonte de proteína, ii) um prebiótico e iii) um probiótico para a fabricação de uma composição nutricional para o tratamento ou a prevenção de infecção em um indivíduo alérgico
BR112019012338A2 (pt) liberação de proteína à base de bactérias de virulência atenuada
BR112017023636A2 (pt) suplemento dietético
IL284799A (en) Tyk2 inhibitors and uses thereof
BR112016019592A8 (pt) Composto, uso de um composto, e, composição farmacêutica
CY1124286T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
EA201791401A1 (ru) СПОСОБ ТЕРАПЕВТИЧЕСКОГО ЛЕЧЕНИЯ СИНДРОМА РАЗДРАЖЁННОГО КИШЕЧНИКА С ПРЕОБЛАДАНИЕМ ДИАРЕИ С ПРИМЕНЕНИЕМ Bacillus coagulans SBC37-01, MTCC 5856
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
EP3955942C0 (en) PROBIOTIC COMPOSITIONS AND RELATED USES
NZ757708A (en) Applications of spermine and its derivative in preparation of antitumor drug
MX2021008072A (es) Composicion prebiotica y su uso.
HUP2300193A1 (hu) Lactobacillus suantsaii törzs és alkalmazása
PL428215A1 (pl) Odczynnik do ochrony mikroorganizmów podczas liofilizacji
JP1813052S (ja) 輪形おしゃぶり